Newly confirmed US Department of Agriculture (USDA) Secretary Brooke Rollins, JD, today introduced new steps to battle avian flu in poultry and stabilize the egg supply, which includes $500 million to help poultry producers shore up biosecurity measures.

A veterinary pharmaceutical company said they have received a conditional license for a bird flu vaccine to be used on chickens, potentially marking the first step toward mitigating a disease that has affected more than 150 million birds in the United States since 2022.

Center for Veterinary Biologics (CVB) issued Zoetis Inc (NYSE:ZTS) a conditional license for its Avian Influenza Vaccine, H5N2 Subtype, Killed Virus. The vaccine is labeled for use in chickens. The conditional license was granted on the demonstration of safety,

DELMARVA - The U.S. Department of Agriculture has granted a conditional license for drug company Zoetis' vaccine for avian influenza.

A New Jersey pharmaceutical company has received a “a conditional license" for its bird flu vaccine for use in chickens. An infectious diseases expert comments.

The vaccine from Zoetis, Avian Influenza Vaccine, H5N2 Subtype, Killed Virus, is for poultry and has been demonstrated to be safe, pure, and to have a reasonable expectation of efficacy

Agricultural officials across the state are urging people who keep domestic poultry to practice proper biosecurity measures amid an outbreak of bird flu. A strain of bird flu called Highly Pathogenic Avian Influenza,

The US Department of Agriculture (USDA) Center for Veterinary Biologics (CVB) has issued a conditional license for an avian influenza vaccine, H5N2 subtype, killed virus. The vaccine, manufactured by Zoetis, is labeled for use in chickens.